tldrdailynews.com logo

New Weight-Loss Drug Zepbound Shows Promise for Treating Sleep Apnea

1 min read
Source: The New York Times
New Weight-Loss Drug Zepbound Shows Promise for Treating Sleep Apnea
Photo: The New York Times
TL;DR Summary

New research indicates that tirzepatide, the compound in the weight-loss drug Zepbound, significantly improves symptoms of obstructive sleep apnea in people with obesity. Clinical trials showed promising results, and Eli Lilly has requested FDA approval to broaden the drug's use to include treating sleep apnea, potentially offering a new management option for the condition.

Topics:top-news#clinical-trials#fda-approval#health#sleep-apnea#tirzepatide#weight-loss
Share this article
  1. Weight-Loss Drug Zepbound Offers a New Way to Treat Sleep Apnea  The New York Times
  2. Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year  CNBC
  3. Weight loss drug could ease sleep apnoea in people with obesity, study says  The Guardian
  4. Mounjaro Drug Tirzepatide Could Treat Sleep Apnea, Study Finds  Forbes

Reading Insights

Total Reads

0

Unique Readers

18

Time Saved

2 min

vs 3 min read

Condensed

88%

447 → 54 words

Want the full story? Read the original article

Read on The New York Times